149 related articles for article (PubMed ID: 15492910)
1. Efficacy of five days of subcutaneous octreotide treatment after sclerotherapy in preventing rebleeding from esophageal varices.
Yücesoy M; Başkol M; Keklik M; Güven M; Sungur M; Gürsoy S; Güven K; Ozbakir O
Turk J Gastroenterol; 2004 Sep; 15(3):137-43. PubMed ID: 15492910
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2 days versus 5 days of octreotide infusion along with endoscopic therapy in preventing early rebleed from esophageal varices: a randomized clinical study.
Rengasamy S; Ali SM; Sistla SC; Lakshmi CP; Harichandra Kumar KT
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):386-92. PubMed ID: 25874510
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
[TBL] [Abstract][Full Text] [Related]
4. Octreotide for esophageal variceal bleeding treated with endoscopic sclerotherapy: a randomized, placebo-controlled trial.
Morales GF; Pereira Lima JC; Hornos AP; Marques DL; Costa CS; Lima Pereira L; Lopes CV; Raymondi R; Marroni CA
Hepatogastroenterology; 2007; 54(73):195-200. PubMed ID: 17419259
[TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy with or without octreotide for acute variceal bleeding.
Besson I; Ingrand P; Person B; Boutroux D; Heresbach D; Bernard P; Hochain P; Larricq J; Gourlaouen A; Ribard D
N Engl J Med; 1995 Aug; 333(9):555-60. PubMed ID: 7623904
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy plus octreotide versus sclerotherapy alone in the management of gastro-oesophageal variceal hemorrhage.
Shah HA; Mumtaz K; Jafri W; Abid S; Hamid S; Ahmad A; Abbas Z
J Ayub Med Coll Abbottabad; 2005; 17(1):10-4. PubMed ID: 15929518
[TBL] [Abstract][Full Text] [Related]
7. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis.
Zuberi BF; Baloch Q
Am J Gastroenterol; 2000 Mar; 95(3):768-71. PubMed ID: 10710072
[TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: a randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club.
Primignani M; Andreoni B; Carpinelli L; Capria A; Rocchi G; Lorenzini I; Staudacher C; Beretta L; Motta R; de Franchis R
Hepatology; 1995 May; 21(5):1322-7. PubMed ID: 7737638
[TBL] [Abstract][Full Text] [Related]
9. Octreotide in acute bleeding esophageal varices: a prospective randomized study.
Freitas DS; Sofia C; Pontes JM; Gregório C; Cabral JP; Andrade P; Rosa A; Camacho E; Ferreira M; Portela F; Romãozinho JM; Tomé L; Gouveia H; Leitão M; Pimenta I; Donato A
Hepatogastroenterology; 2000; 47(35):1310-4. PubMed ID: 11100339
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicentric, and randomized clinical trial.
Bildozola M; Kravetz D; Argonz J; Romero G; Suarez A; Jmelnitzky A; Fainberg M; Fassio E; Berreta J; Romero G; Landeira G; Martinez H; Bosco A; Guevara M; Valero J; Chopita N; Berenstein G; Terg R
Scand J Gastroenterol; 2000 Apr; 35(4):419-25. PubMed ID: 10831267
[TBL] [Abstract][Full Text] [Related]
11. [Octreotide administration and/or endoscopic treatment in cirrhotic patients with acute variceal bleeding: a multicentric study].
Silva G; Quera R; Fluxá F; Sanhueza E; Segovia R; Brahm J; Muñoz C; Morales A; Muñoz L; Urzúa L; Biagini L
Rev Med Chil; 2004 Mar; 132(3):285-94. PubMed ID: 15376564
[TBL] [Abstract][Full Text] [Related]
12. Prevention of variceal rebleeding.
Burroughs AK; McCormick PA
Gastroenterol Clin North Am; 1992 Mar; 21(1):119-47. PubMed ID: 1349003
[TBL] [Abstract][Full Text] [Related]
13. [Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging].
Villanueva C; Martínez FJ; Torras X; Sáinz S; Soriano G; González D; Balanzó J
Rev Esp Enferm Dig; 1994 Jul; 86(1):499-504. PubMed ID: 7917561
[TBL] [Abstract][Full Text] [Related]
14. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.
Escorsell A; Bordas JM; del Arbol LR; Jaramillo JL; Planas R; Bañares R; Albillos A; Bosch J
J Hepatol; 1998 Nov; 29(5):779-88. PubMed ID: 9833916
[TBL] [Abstract][Full Text] [Related]
16. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage.
Sung JJ; Chung SC; Lai CW; Chan FK; Leung JW; Yung MY; Kassianides C; Li AK
Lancet; 1993 Sep; 342(8872):637-41. PubMed ID: 8103145
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
Lundell L; Leth R; Lind T; Lönroth H; Sjövall M; Olbe L
Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
[TBL] [Abstract][Full Text] [Related]
18. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.
D'Amico G; Politi F; Morabito A; D'Antoni A; Guerrera D; Giannuoli G; Traina M; Vizzini G; Pasta L; Pagliaro L
Hepatology; 1998 Nov; 28(5):1206-14. PubMed ID: 9794903
[TBL] [Abstract][Full Text] [Related]
19. Secondary prophylaxis of esophageal variceal treatment: Endoscopic sclerotherapy, band ligation and combined therapy--long-term results.
Kuran S; Oğuz D; Parlak E; Asil M; Ciçek B; Kiliç M; Dişibeyaz S; Sahin B
Turk J Gastroenterol; 2006 Jun; 17(2):103-9. PubMed ID: 16830291
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study].
Cho SB; Park KJ; Lee JS; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS; Kim SJ
Korean J Hepatol; 2006 Sep; 12(3):385-93. PubMed ID: 16998290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
